Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ISRCTN77382043Phase 3Completed
Phase 3, randomised, double-blind trial in prediabetes comparing Metformin extended-release with Matching placebo (2 arms). Primary endpoint: Incidence of diabetes. Started Oct 2021; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ISRCTN77382043.